Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 16/20 | 0.65 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.65 |
| ▸ | FAAH | O00519 | 3/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.50 |
| ▸ | CCR6 | P51684 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL710771 | 0.89 | MGLL (0.70) | MGLLTLR9FAAHHSP90AA1ALDH1A1 | |
| SCHEMBL29440938 | 0.89 | MGLL (0.70) | MGLLTLR9FAAHHSP90AA1ALDH1A1 | |
| SCHEMBL9172497 | 0.86 | MGLL (0.66) | MGLLTLR9FAAHHSP90AA1CCR6 | |
| SCHEMBL5075502 | 0.85 | MGLL (0.58) | MGLLTLR9FAAHHSP90AA1CCR6 | |
| SCHEMBL29757193 | 0.85 | MGLL (0.58) | MGLLTLR9FAAHHSP90AA1CCR6 | |
| SCHEMBL2230828 | 0.85 | MGLL (0.50) | MGLLTLR9FAAHHSP90AA1CCR6 | |
| SCHEMBL7609581 | 0.84 | MGLL (0.72) | MGLLTLR9FAAHHSP90AA1 | |
| SCHEMBL4443401 | 0.80 | MGLL (0.45) | MGLLTLR9FAAHHSP90AA1CCR6 | |
| SCHEMBL11642863 | 0.80 | TDP1 (0.58) | MGLLTLR9FAAHHSP90AA1CCR6 | |
| SCHEMBL121404 | 0.79 | TLR9 (1.00) | MGLLTLR9FAAHHSP90AA1CCR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 339 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240351981-A1 | NOVEL BISMALEIMIDE COMPOUNDS HAVING IMPROVED SOLUBILITY AND THEIR USE IN CURABLE COMPOSITIONS | EVONIK OPERATIONS GMBH (DE) | 2024-10-24 | — | — | US | claimed |
| EP-4380922-A1 | NOVEL BISMALEIMIDE COMPOUNDS HAVING IMPROVED SOLUBILITY AND THEIR USE IN CURABLE COMPOSITIONS | Evonik Operations GmbH (DE) | 2024-06-12 | — | — | EP | claimed |
| CN-117813286-A | Novel bismaleimide compounds with improved solubility and their use in curable compositions | 赢创运营有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117645771-A | Solvent-free high-low temperature resistant bulletproof composite matrix resin and preparation method thereof | 上海鑫丰泰新材料科技有限公司 | 2024-03-05 | — | — | CN | claimed |
| WO-2023011938-A1 | NOVEL BISMALEIMIDE COMPOUNDS HAVING IMPROVED SOLUBILITY AND THEIR USE IN CURABLE COMPOSITIONS | EVONIK OPERATIONS GMBH (DE) | 2023-02-09 | — | — | WO | claimed |
| CN-109982993-B | Asymmetrically substituted dienyl diphenyl ethers, their preparation and use | 赢创运营有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-108349861-B | Alkenylphenoxy-substituted 1, 1-diphenylethylenes, process for their preparation and their use | 赢创运营有限公司 | 2021-07-20 | — | — | CN | claimed |
| CN-108137458-B | [ (2-ethoxy-5-trans-1-propen-1-yl) -phenoxy ] -end-capping compounds | 赢创运营有限公司 | 2021-01-05 | — | — | CN | claimed |
| EP-3541773-B1 | ASYMMETRICALLY SUBSTITUTED BIS-ALKENYL DIPHENYL ETHERS, THEIR PREPARATION AND USE | EVONIK OPERATIONS GMBH (DE) | 2020-05-13 | — | — | EP | claimed |
| EP-3350150-B1 | ALKENYLPHENOXY-SUBSTITUTED 1,1-DIPHENYLETHYLENES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE | EVONIK OPERATIONS GMBH (DE) | 2020-02-19 | — | — | EP | claimed |
| EP-0230741-A2 | Curable resins | Technochemie GmbH - Verfahrenstechnik (DE) | 1987-08-05 | — | — | EP | claimed |
| EP-0212808-A2 | Curable resins | Technochemie GmbH - Verfahrenstechnik (DE) | 1987-03-04 | — | — | EP | claimed |
| EP-0131027-B1 | CURABLE THERMOSETTING PREPOLYMERISED IMIDE RESIN COMPOSITIONS | The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and (GB) | 1986-12-17 | — | — | EP | claimed |
| EP-0165812-A2 | Thermosetting imide resin compositions | The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and (GB) | 1985-12-27 | — | — | EP | claimed |
| EP-0141612-A2 | Curable Bisimide Resin Mixtures | Technochemie GmbH - Verfahrenstechnik (DE) | 1985-05-15 | — | — | EP | claimed |
| EP-0131027-A1 | CURABLE THERMOSETTING PREPOLYMERISED IMIDE RESIN COMPOSITIONS. | SECR DEFENCE BRIT (GB) | 1985-01-16 | — | — | EP | claimed |
| WO-1984002528-A1 | CURABLE THERMOSETTING PREPOLYMERISED IMIDE RESIN COMPOSITIONS | SECR DEFENCE BRIT (GB) | 1984-07-05 | — | — | WO | claimed |
| US-4356227-A | AMINO ACID HYDRAZIDE-MODIFIED UNSATURATED BISIMIDE POLYMER; LAMINATION; MECHANICAL PROPERTIES | TECHNOCHEMIE GMBH (DE) | 1982-10-26 | — | — | US | claimed |
| US-4303779-A | Thermosetting imide resins from dihydrazide | TECHNOCHEMIE GMBH-VERFAHRENSTECHNIK (DE) | 1981-12-01 | — | — | US | claimed |
| US-4211860-A | N,N*-BISMALEIMIDE | TECHNOCHEMIE GMBH VERFAHRENSTECHNIK (DE) | 1980-07-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240351981-A1 | NOVEL BISMALEIMIDE COMPOUNDS HAVING IMPROVED SOLUBILITY AND THEIR USE IN CURABLE COMPOSITIONS | PBRM1, SMCHD1, SMARCE1 | MGLL 3949/4885TLR9 2754/4885FAAH 1732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.